Tarsus Pharmaceuticals Inc (TARS)

Jan 30, 2025

Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire

Jan 30, 2025

Jan 30, 2025

Exclusive Access: Tarsus Pharma's Double-Header at Elite Healthcare Investment Forums - StockTitan

Jan 30, 2025

Jan 30, 2025

Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.

Jan 30, 2025

Jan 28, 2025

How To Trade (TARS) - Stock Traders Daily

Jan 28, 2025

Jan 28, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Given New $62.00 Price Target at Barclays - Defense World

Jan 28, 2025

Jan 28, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Up 9% After Analyst Upgrade - Defense World

Jan 28, 2025

Jan 27, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 9% Higher After Analyst Upgrade - MarketBeat

Jan 27, 2025

Jan 27, 2025

A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts - Benzinga

Jan 27, 2025

Jan 27, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target Raised to $62.00 at Barclays - MarketBeat

Jan 27, 2025

Jan 25, 2025

Oppenheimer lifts Tarsus stock target, impressed by execution and ocular rosacea potential - MSN

Jan 25, 2025

Jan 25, 2025

Tarsus Pharmaceuticals Inc (NASDAQ: TARS): An Enticing Stock To Watch - Stocks Register

Jan 25, 2025

Jan 24, 2025

Midday Stock Roundup: Virgin Galactic down 2.3% and 87% YoY - Orange County Business Journal

Jan 24, 2025

Jan 23, 2025

Tarsus: Promising Investment, But Timing Is The Key (NASDAQ:TARS) - Seeking Alpha

Jan 23, 2025

Jan 23, 2025

Oppenheimer Increases Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $72.00 - MarketBeat

Jan 23, 2025

Jan 22, 2025

First Week of TARS March 21st Options Trading - Nasdaq

Jan 22, 2025

Jan 21, 2025

Tarsus PharmaceuticalEye Care Therapeutics - MSN

Jan 21, 2025

Jan 20, 2025

Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey

Jan 20, 2025

Jan 20, 2025

Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks - Insider Monkey

Jan 20, 2025

Jan 19, 2025

Tarsus Pharmaceuticals reshuffles board, appoints new committee chair By Investing.com - Investing.com South Africa

Jan 19, 2025

Jan 18, 2025

Tarsus Pharmaceuticals reshuffles board, appoints new committee chair - MSN

Jan 18, 2025

Jan 18, 2025

Grant GrossMendelsohn LLC Sells 14,331 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Jan 18, 2025

Jan 18, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $54.20 Average Target Price from Analysts - MarketBeat

Jan 18, 2025

Jan 18, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Jan 18, 2025

Jan 18, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Publishes Corporate Presentation – Enhances Stakeholder InsightOn January 13, 2025, Tarsus Pharmaceuticals, Inc. shared its corporate presentation on its website’s Investor & News section, as detailed in the lates - Defense World

Jan 18, 2025

Jan 18, 2025

Tarsus Pharmaceuticals, Inc Announces Board and Committee Changes -January 17, 2025 at 05:09 pm EST - Marketscreener.com

Jan 18, 2025

Jan 16, 2025

Assenagon Asset Management S.A. Buys 5,565 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Jan 16, 2025

Jan 15, 2025

Down -9.11% in 4 Weeks, Here's Why Tarsus Pharmaceuticals (TARS) Looks Ripe for a Turnaround - MSN

Jan 15, 2025

Jan 14, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Down 6.3%Time to Sell? - MarketBeat

Jan 14, 2025

Jan 14, 2025

Tarsus Pharmaceuticals is Now Oversold (TARS) - Nasdaq

Jan 14, 2025

Jan 13, 2025

Tarsus CEO Bobby Azamian: Clearing Crusty Eyelids with Xdemvy - Orange County Business Journal

Jan 13, 2025

Jan 13, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap DownTime to Sell? - MarketBeat

Jan 13, 2025

Jan 13, 2025

Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY - WICZ

Jan 13, 2025

Jan 13, 2025

Tarsus Provides 2025 Update: Accelerating the Launch of - GlobeNewswire

Jan 13, 2025

Jan 13, 2025

Tarsus' XDEMVY Eye Treatment Hits $113M Sales, Plans New Rosacea Drug Development - StockTitan

Jan 13, 2025

Jan 12, 2025

Analysts Expect Breakeven For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Before Long - Simply Wall St

Jan 12, 2025

Jan 11, 2025

JPMorgan Chase & Co. Has $14.48 Million Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Jan 11, 2025

Jan 11, 2025

JPMorgan Chase & Co. Buys 420,057 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Jan 11, 2025

Jan 08, 2025

Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength? - Yahoo Finance

Jan 08, 2025

Jan 01, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Bought by Franklin Resources Inc. - Defense World

Jan 01, 2025

Dec 31, 2024

Tarsus Pharmaceuticals stock soars to 52-week high of $56.84 By Investing.com - Investing.com Australia

Dec 31, 2024

Dec 30, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month HighHere's What Happened - MarketBeat

Dec 30, 2024

Dec 30, 2024

Tarsus Pharmaceuticals stock soars to 52-week high of $56.84 - Investing.com

Dec 30, 2024

Dec 27, 2024

How Tarsus Pharmaceuticals' Unique Inspiration Is Driving A Triple-Digit Run - MSN

Dec 27, 2024

Dec 27, 2024

Geode Capital Management LLC Increases Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Dec 27, 2024

Dec 27, 2024

Geode Capital Management LLC Purchases 62,555 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Dec 27, 2024